TARS (NASDAQ: TARS) insider files Form 144 to resell 4,589 shares after vesting

Rhea-AI Filing Summary

TARS filed a Form 144 reporting proposed sales of Common Stock by a reporting person. The filing lists 4,589 shares to be sold following a restricted stock vesting on 03/18/2026 as compensation. It also discloses prior sales in March: 8,366, 3,125, and 3,610 shares with associated proceeds reported.

Insights

Securities Compliance Counsel

Rule 144 notice of resale after restricted stock vesting; procedural disclosure.

The filing documents a restricted stock vesting event dated 03/18/2026 with 4,589 shares listed under "Securities To Be Sold" as compensation. Rule 144 notices notify the market of intended resales and satisfy resale notice obligations under the Securities Act.

Timing and exact sale methods are not detailed here; subsequent filings or broker records may report execution details or additional dispositions.

Equity Markets Analyst

Small, routine insider dispositions and vesting-related resale activity.

The excerpt shows multiple March transactions: 8,366, 3,125, and 3,610 shares with proceeds noted, and a planned sale of 4,589 shares tied to vesting on 03/18/2026. These sizes are modest in isolation relative to typical public floats.

Cash‑flow treatment and who receives proceeds are not specified in the excerpt; further filings may clarify execution method and final proceeds recipient.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4589	307457.49	42557492	03/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2026	Restricted Stock Vesting	Issuer			4589	03/18/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Seshadri Neervannan 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618	Common	03/04/2026	8366	641421.22
Seshadri Neervannan 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618	Common	03/17/2026	3125	216920.94
Seshadri Neervannan 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618	Common	03/18/2026	3610	248042.38

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does TARS Form 144 disclose about share sales?

The filing discloses a planned resale of 4,589 shares tied to restricted stock vesting on 03/18/2026. It also lists three prior March sales of 8,366, 3,125, and 3,610 shares with proceeds reported.

Who is listed as the reporting person on the TARS Form 144?

The excerpt names Seshadri Neervannan with an address in Irvine, CA, and shows prior sales attributed to that reporting person. The vesting-related resale is shown as issuer compensation on 03/18/2026.

Are proceeds from the March sales shown in the TARS Form 144?

Yes; the March dispositions include proceeds: $641,421.22 for 8,366 shares, $216,920.94 for 3,125 shares, and $248,042.38 for 3,610 shares, as listed in the filing excerpt.

Does the Form 144 specify how the planned 4,589 shares will be sold?

The excerpt characterizes the 4,589 shares as from a restricted stock vesting event and labels the source as "Issuer" for compensation. Specific sale methods or brokers are not detailed in the provided excerpt.

Does the Form 144 indicate whether TARS receives proceeds from the resale?

The vesting entry lists the source as Issuer and compensation; the excerpt does not explicitly state the cash‑flow recipient for the resale proceeds. Further filings may clarify proceeds treatment.